Insider Trading February 25, 2026

IonQ Director Sells $19,096 in Stock as Company Posts Strong Q4 2025 Results

Gabrielle B. Toledano liquidates 616 shares under a 10b5-1 plan; IonQ beats EPS and revenue estimates for the quarter

By Derek Hwang IONQ
IonQ Director Sells $19,096 in Stock as Company Posts Strong Q4 2025 Results
IONQ

Gabrielle B. Toledano, a director at IonQ, Inc. (NASDAQ: IONQ), sold 616 shares on February 24, 2026, for $19,096 at $31 per share under a Rule 10b5-1 plan. The stock has since traded up to $33.59 but remains about 25% lower year-to-date. IonQ reported stronger-than-expected fourth-quarter 2025 results, with EPS of -$0.20 compared with an expected -$0.51 and revenue of $61.9 million versus a $40.38 million forecast. Analysts have not reported any rating changes following the earnings release.

Key Points

  • Director Gabrielle B. Toledano sold 616 shares on February 24, 2026, at $31 per share, totaling $19,096, and now directly holds 9,385 shares.
  • IonQ’s Q4 2025 results beat expectations: EPS of -$0.20 versus an anticipated -$0.51 (60.78% surprise) and revenue of $61.9 million versus $40.38 million forecast.
  • Shares have moved to $33.59 after the sale but are still down about 25% year-to-date amid volatility; InvestingPro analysis flags the company as appearing overvalued relative to its Fair Value.

IonQ, Inc. (NASDAQ: IONQ) disclosed that director Gabrielle B. Toledano sold 616 shares of company common stock on February 24, 2026. The transaction generated proceeds of $19,096, reflecting a sale price of $31.00 per share.

Following the disposition, Toledano’s direct holdings in IonQ stand at 9,385 shares. The sale was executed pursuant to a Rule 10b5-1 trading arrangement that the director adopted on September 11, 2025.

Market action since the trade shows IonQ shares reaching $33.59, though the stock remains roughly 25% lower year-to-date amid notable volatility. Independent valuation commentary included in InvestingPro analysis indicates the quantum computing company appears overvalued relative to its Fair Value, according to the platform’s evaluation.

On the corporate results front, IonQ reported fourth-quarter 2025 earnings that exceeded Wall Street expectations. The company recorded diluted earnings per share of -$0.20, outperforming the consensus estimate of -$0.51 by a margin that equates to a 60.78% surprise. Revenue for the quarter was $61.9 million, topping the projected $40.38 million figure. These metrics were received positively by investors in aftereffects to the release.

Despite the stronger-than-expected quarter, the company has not received any analyst upgrades or downgrades following the announcement, and the reporting reflects a single quarter of financial performance rather than a change in long-term guidance.


Contextual note: The sale was conducted under an established trading plan, and the company’s recent quarterly performance produced top-line and bottom-line beats compared with expectations. The share sale, year-to-date price decline, valuation assessment from InvestingPro, and the absence of analyst rating changes are all elements that market participants can weigh when assessing IonQ’s near-term stock narrative.

Risks

  • Significant share price volatility - the stock remains approximately 25% lower year-to-date, which elevates market risk for shareholders and traders in the technology and broader equity markets.
  • Valuation concern - InvestingPro analysis indicates IonQ currently appears overvalued relative to its Fair Value, representing a potential downside risk for investors assessing the quantum computing sector.
  • Insider selling context - while the transaction was executed under a Rule 10b5-1 plan, insider sales can be interpreted in different ways by market participants and may influence investor sentiment in the technology and capital markets.

More from Insider Trading

Immunovant CEO Disposes $342,854 in Shares After Large CVAR Conversion Apr 3, 2026 Oklo CEO and Spouse Dispose of $10.07 Million in Class A Shares Apr 3, 2026 Etsy Executive Chair Sells Shares Amid Large Vesting; Analysts Offer Mixed Views Apr 3, 2026 Oklo CFO Disposes of $834,749 in Stock; Exercises Options as Company Navigates Volatile Trading and Strategic Moves Apr 3, 2026 Newmont Executive Sells $339K in Stock as Gold Market Headwinds Persist Apr 3, 2026